UMS HOLDINGS LIMITED (SGX:558)
VENTURE CORPORATION LIMITED (SGX:V03)
AZTECH GLOBAL LTD. (SGX:8AZ)
AEM HOLDINGS LTD (SGX:AWX)
INNOTEK LIMITED (SGX:M14)
FRENCKEN GROUP LIMITED (SGX:E28)
NANOFILM TECHNOLOGIES INTL LTD (SGX:MZH)
Tech Manufacturers Stocks - Focus On Stocks With Diversified Customer Base & Low Production Disruptions
- We expect earnings weakness for stocks with huge China exposure – NanoFilm Technologies, Aztech Global and InnoTek due to lockdowns in China since late-1Q22. In contrast, stocks with low China exposure and a diverse customer base – Venture Corp and Frencken should deliver more resilient earnings.
- Pure semiconductor names – AEM and UMS should deliver healthy earnings but we are cautious of a slowdown in the semiconductor cycle.
- Our top picks are Venture Corp and Frencken for their diversified customer base and pricing power.
SGX listed tech-related companies scheduled to release their 2Q22 results between 25 July and 15 August.
- Tech companies under our coverage will be releasing their 2Q22 results starting from next week with Aztech Global scheduled to report on 25 July and Venture Corp on 5 August. See Earnings Calendar.
- We categorise the stocks into 3 groups:
- stocks with significant China exposure (NanoFilm Technologies (SGX:MZH), Aztech Global (SGX:8AZ), InnoTek (SGX:M14)),
- stocks with low China exposure and diverse customer base (Venture Corp (SGX:V03), Frencken (SGX:E28)), and
- pure semiconductor names with large single customers (AEM (SGX:AWX), UMS (SGX:558)).
- Our top picks are Venture Corp and Frencken as we believe their diversified customer base and majority of productions in Malaysia, which have fully relaxed its COVID-19 restrictions, should reduce the negative impact of weaker demand as well as supply chain disruptions.
Tech stocks that have majority of their production bases in China could see negative earnings surprises.
- In late-1Q22, China rolled out its biggest COVID-19 lockdown since the start of the pandemic as Shanghai confined residents to their homes. Although Shanghai has reopened after two months, sporadic lockdowns are still very common across China. This has caused persistent challenges to the manufacturing supply chain.
- Three key challenges include:
- higher costs in sourcing for raw materials due to reduced supply and higher logistics costs,
- higher labour costs due to the requirement of closed-loop manufacturing, and
- slowdown in customers’ demand due to difficulties in sourcing materials and slower productions.
- As a result, we think NanoFilm (Shanghai), Aztech (Dongguan) and InnoTek (Dongguan and Suzhou), which have majority of their production plants in China, could see negative earnings surprises in their upcoming 1H22 results.
- Also, these manufacturers serve customers in the consumer electronics and auto segments, which are discretionary products in nature, and could see reduced demand in a recession.
Tech stocks with low China exposure and diverse customer base should deliver more resilient earnings.
- We believe Venture Corp should continue to deliver a good set of results in 2Q22 as:
- it continues to see healthy demand from most of its customers which are diversified across seven domains, and
- it has a proven capability in managing supply chain disruptions.
- In addition, Venture Corp should be able to manage costs and pass on higher prices to customers given its differentiated capabilities.
- On the other hand, we expect Frencken to show a marginal decline in its 1H22 earnings due to higher material costs which will drag its gross margin. However, 2H22 earnings should be sequentially better as management is working to mitigate cost inflation pressures by passing on cost increases through operational initiatives, and is anticipating signs of easing supply chain constraints.
- Also, Frencken’s diversified customer base across five segments should provide better earnings visibility.
Pure semiconductor names should report healthy earnings but we are cautious of a slowdown in the semiconductor cycle.
- Although we expect both AEM and UMS to report healthy earnings growth for 2Q22, we are wary of a slowdown in the semiconductor cycle after two years of strong chip demand that was partially boosted by the supply chain disruptions caused by the COVID-19 pandemic.
- Chipmakers' fortunes rose in the early days of the pandemic as demand for electronics from stuck-at-home consumers and reduced supply due to manufacturing and logistics issues caused semiconductor demand to soar. Amid the supply crunch, businesses across the chip value chain raced to stockpile chips so they could handle further disruptions.
- In TSMC’s latest earnings call, it warned that its customers might now draw on those chip reserves rather than place new orders. TSMC also said it would trim its capex for 2022 by 10% to US$40b.
- South Korean chipmaker SK Hynix is also considering reducing its 2023 capex by 25%.
- On 7 Jun 22, Intel CFO said that he expected the US chipmaker's 2Q22 earnings to take a hit due to customers working through stockpiled inventory instead of placing new orders. In addition, demand for electronics is softening as PC shipments in 2Q22 fell 12.6 y-o-y, according to consulting firm Gartner.
- The crypto crash could be another drag on the chip market as crypto miners cease operations. Shipments of graphics cards fell 19% y-o-y in 1Q22, according to consulting firm Jon Peddie Research.
Maintain OVERWEIGHT but be selective on names with diversified customer base and lower China exposure.
- We recommend investors to focus on our top picks, Venture Corp and Frencken as we believe their diversified customer base and majority of productions in Malaysia, which have fully relaxed its COVID-19 restrictions, should reduce the negative impact of weaker demand as well as supply chain disruptions.
Venture Corp (SGX:V03)
- Expect Venture Corp's earnings to grow 13% y-o-y but remain flat q-o-q; demand from customers remain healthy. We expect Venture Corp to report 2Q22 earnings of S$85m (+13% y-o-y, +1% q-o-q). Venture Corp continues to see healthy demand from most of its customers.
- Despite the increasingly uncertain environment, Venture Corp should be able to deliver relatively resilient performance given its highly diversified customer base across seven technology domains. In addition, most of Venture Corp’s customers are in industrial segments such as life science, medical and testing, which are less sensitive to consumer sentiment.
- Maintain BUY call on Venture Corp with target price of S$22.80, pegged at +1 standard deviation above its forward mean P/E, of 19.5x on 2022F earnings. Currently, Venture Corp offers an attractive dividend yield of 4.7%.
- See
Frencken (SGX:E28)
- Expect continued weakness in Frencken's 2Q22 results but look forward for a better 2H22. We expect 2Q22 earnings of S$13m (-22% y-o-y / +2% q-o-q) from Frencken as impacts from supply chain disruptions, higher cost pressures from raw materials, rising energy prices and workforce disruptions will take time to ease. However, we expect 2H22 earnings to be sequentially better as management is working to mitigate cost inflation pressures by passing on cost increases through operational initiatives and is anticipating signs of easing supply chain constraints.
- In the mid to longer term, Frencken would benefit from positive market trends in 5G, Internet Of Things and artificial intelligence.
- Maintain BUY call on Frencken with target price of S$1.63, pegged to 10.4x 2022F P/E, based on historical mean P/E. Currently, Frencken trades at an attractive 7x 2022F P/E.
- See
NanoFilm Technologies (SGX:MZH)
- Expect lacklustre 1H22 earnings from Nanofilm due to margin pressure from production disruption in China and more cautious outlook of major customer. We expect NanoFilm to report 1H22 earnings of S$20m (+12% y-o-y / -55% h-o-h vs 2H21), falling short of our estimated 26% y-o-y growth in 2022 earnings. The weakness can be mainly attributable to production disruptions caused by the two-month lockdown in Shanghai in April and May 22, and is likely to impact gross margins from higher labour and raw material costs due to logistical challenges.
- Moving forward, we also see a more cautious outlook from NanoFilm’s largest customer, as it had announced in Jul 22 that it is planning to slow hiring and spending growth next year in some divisions to cope with a potential economic downturn.
- Maintain HOLD call on NanoFilm with a target price of S$2.72. We value NanoFilm based on PEG of 1.0x (growth based on 3-year EPS CAGR of 23% from 2021-24). Our target P/E multiple of 23x 2022F P/E is at a slight discount vs NanoFilm’s peers’ 25x 2022F P/E.
- See
Aztech Global (SGX:8AZ)
- Expect marginal earnings growth for Aztech in 2Q22 but turning more cautious on consumer sentiment and margin weakness. We expect Aztech to report 2Q22 earnings of S$18m (+5% y-o-y, +22% q-o-q), where the 1H22 of S$30m will fall short of our expectation of S$36m mainly due to production disruption in China. Hence, we will be looking at a potential 10% cut in our 2022 earnings estimate of S$90m. This should have an impact on Aztech’s revenue and gross margin as higher logistics and labour costs may not be fully passed on to customers.
- In addition, Aztech’s key product of surveillance camera, which is discretionary in nature, may see slower demand in a more uncertain environment.
- Maintain BUY call on Aztech with target price of S$1.55, pegged to 13.3x 2022F earnings, which is based on its Singapore and Malaysia peers’ average.
- See
InnoTek (SGX:M14)
- Innotek issued a profit guidance for 1H22 on 14 July, highlighting that it expects to report a net loss for 1H22 due to increased operating costs as labour and manufacturing costs have risen, while disruptions to the global supply chain have resulted in higher cost of raw materials and prolonged movement restrictions imposed within China as part of its “zero- COVID” policy. These restrictions severely impacted InnoTek’s major customers’ businesses in China, which in turn hampered InnoTek’s revenue growth in 1H 22.
- We thus place the stock UNDER REVIEW pending further information from its 1H22 results. Our last call for InnoTek was BUY with a PE-based target price of S$1.20, based on a 12x 2022F P/E.
- See
AEM (SGX:AWX)
- Expect AEM's 2Q22 earnings to grow strongly y-o-y but decline q-o-q. We are expecting AEM (SGX:AWX) to report 2Q22 earnings of S$25m (+52% y-o-y, -39% q-o-q), with the sequential decline from an exceptionally strong 1Q22 mainly driven by the uptake in new generation equipment and tools and the consolidation of CEI Limited, which was acquired in 1H21.
- We also believe that there could have been some front-loading of orders in 1Q22 as the major customer attempts to mitigate the risk of supply chain constraints. On 7 Jun 22, Intel CFO stated that he expected the US chipmaker's 2Q22 earnings to take a hit due to customers working through stockpiled inventory instead of placing new orders.
- Maintain BUY call on AEM with target price of S$5.60. The target price is pegged to 2022 earnings of 15.6x, or +2 standard deviation to its historical five-year range, supported by a forward ROE of 25.6%. This compares to the Singapore peer average forward P/E of 10.1x and forward ROE of 20.6%. The valuation peg is supported by the positive outlook for AEM from 2022 onwards and the anticipated cyclical upturn of AEM’s business.
- See
UMS (SGX:558)
- Expect a healthy y-o-y and stable q-o-q earnings growth from UMS in 2Q22. We are expecting UMS to report 2Q22 earnings of S$19m (+12% y-o-y / -2% q-o-q), as the company should enjoy continued strength in semiconductor demand, as well as consolidation of sales from JEP (SGX:1J4) starting in 2Q21. We understand that factory utilisation levels at the downstream semiconductor manufacturers, including UMS, will stay elevated in 2022-23.
- Specifically for UMS, the order backlog for AMAT’s Semi Systems segment has shown sustained growth over the past four consecutive quarters, providing revenue visibility for UMS into 2023.
- Maintain BUY call on UMS with target price of S$1.45, pegged to 15.4x 2022F earnings, or +2 standard deviation above its historical 5-year average. We believe UMS could trade at a premium over peers due to its timely new capacity expansion to drive earnings growth above the industry average.
- See
Sector Catalysts
- Increasing capex spending by upstream global tech manufacturers.
- Better-than-expected 2Q22 sales and net profit numbers.
Sector Risks
- Reduced demand for electronic goods as a result of global recession.
- Escalation of geopolitical tension and trade conflict between the US and China.
- See SGX listed companies' upcoming earnings release dates at Earnings Calendar.
John Cheong
UOB Kay Hian Research
|
https://research.uobkayhian.com/
2022-07-21
SGX Stock
Analyst Report
1.450
SAME
1.450
22.800
SAME
22.800
1.550
SAME
1.550
5.600
SAME
5.600
99998
SAME
1.200
SGX Stock
Analyst Report
1.630
SAME
1.630
2.720
SAME
2.720